Product Images Anastrozole

This is a medication called Anastozole with a warning not to take it while pregnant. It is important to keep it out of reach of children. The package contains 15 round tablets with each tablet having 1mg of Anastozole. The package insert provides information about dosage and storage. There are specific lot and expiry details mentioned on the package. This medication might have side effects and it is advised to seek medical advice if needed. Contact FDA at 1-800-FDA-1088 to report any side effects. The text also provides dosage information in Spanish.*

This is a chart showing disease-free survival in months for patients who were randomized to receive treatment with either anastrozole or tamoxifen. The chart displays the proportion of patients who remained alive and disease-free over time. The number of patients at risk for each treatment is listed at the bottom of the chart.*

This appears to be a graph or chart showing the proportion of patients alive and disease-free over time based on a randomized treatment of either anastrozole or tamoxifen. The x-axis measures disease-free survival in months, while the y-axis shows the proportion of patients who remain alive and disease-free. The chart also includes a legend indicating which line represents each treatment, as well as a table showing the number of patients at risk for each treatment at various time points.*

This is a Kaplan-Meier curve comparing the time to an event (possibly a medical condition) for patients who received either anastrozole or tamoxifen. The graph displays the number of patients at risk at certain time points up to 120 months. However, the text is heavily distorted and contains non-readable characters.*

This is a graph displaying the proportion of event-free patients over time in months for a randomized treatment of anastrozole and tamoxifen. The number of patients at risk is also shown. The vertical axis has been truncated to improve clarity.*

This appears to be a graph or chart of some kind. The title suggests that the topic is related to a lack of progress, but without more context, it is difficult to determine the specific subject matter.*

The information provided is a comparison of two types of treatments, ANASTROZOLE, and TAMOXIFEN, for a condition that is not progressing adequately. The data shows a randomized treatment with measurements over a time of 0 to 6 months with the percentage of people in the study that progress with each treatment. The chart also shows the time to the progression of the treatment in months.*